vascular grafting

血管移植
  • 文章类型: Journal Article
    血管移植物感染(VGI)是动脉重建手术后最严重的并发症之一。在过去的十年中,VGI受到了越来越多的关注,但是关于它的诊断和管理仍然存在许多问题。在这次审查中,我们通过多学科合作来描述我们的VGI方法,并讨论具有挑战性的演示文稿的决策。本文件将集中于影响动脉瘤和假性动脉瘤的VGI,不包括升主动脉。
    Vascular graft infection (VGI) is one of the most serious complications following arterial reconstructive surgery. VGI has received increasing attention over the past decade, but many questions remain regarding its diagnosis and management. In this review, we describe our approach to VGI through multidisciplinary collaboration and discuss decision-making for challenging presentations. This document will concentrate on VGI that impacts both aneurysms and pseudoaneurysms excluding the ascending thoracic aorta.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Systematic Review
    背景:我们研究了解剖和解剖外旁路治疗单侧髂动脉疾病的长期安全性和有效性。
    方法:在PubMed上进行系统搜索,Scopus和Webofscience为2023年6月发表的文章进行了表演。我们使用DerSimonian和Laird的多变量方法进行了两阶段个体参与者数据(IPD)荟萃分析和汇总生存概率。主要终点是随访5年和10年的主要通畅性。
    结果:纳入10项研究,包括1907例患者。解剖搭桥的五年和十年合并原发性通畅率为83.27%(95%CI:69.99-99.07)和77.30%(95%CI:60.32-99.04),平均主要通畅时间代表个体保持无事件的持续时间为10.08年(95%CI:8.05-10.97).解剖外搭桥的五年和十年合并原发性通畅率为77.02%(95%CI:66.79-88.80)和68.54%(95%CI:53.32-88.09),平均原发性通畅时间为9.25年,(95%CI:7.21-9.68)。在两阶段IPD荟萃分析中,解剖搭桥显示,与解剖外搭桥相比,原发性通畅性丧失的风险降低。风险比(HR)0.51(95%CI:0.30-0.85)。解剖搭桥的五年和十年二次通畅率分别为96.83%(95%CI:90.28-100)和96.13%(95%CI:88.72.3-100)。解剖外搭桥的五年和十年二次通畅率为91.39%(95%CI:84.32-99.04)和85.05%(95%CI:74.43-97.18),两组间差异无统计学意义。解剖搭桥术患者的5年和10年生存率分别为67.99%(95%CI:53.84-85.85)和41.09%(95%CI:25.36-66.57)。解剖外搭桥术的五年和十年生存率分别为70.67%(95%CI:56.76-87.98)和34.85%(95%CI:19.76-61.44)。解剖组的平均生存时间为6.92年(95%CI:5.56-7.89),解剖外组的平均生存时间为6.78年(95%CI:5.31-7.63)。汇总的30天总死亡率为2.32%(95%CI:1.12-3.87),荟萃回归分析显示发表年份与死亡率之间呈负相关(β=-0.0065,p<0.01)。进一步分析显示30天死亡率为1.29%(95%CI:0.56-2.26)与4.02%(95%CI:1.78-7.03),(p=0.02),用于2000年之后和之前发表的研究。两组之间在长期和30天死亡率方面的差异无统计学意义。
    结论:虽然我们已经证明两种手术技术的长期原发性和继发性通畅性良好,解剖搭桥术降低了原发性通畅性丧失的风险,这可能反映了其在远端主动脉和对侧供体动脉中规避预期疾病进展的固有能力.在我们的综述中观察到的围手术期死亡率的降低,再加上现有文献中提出的不合时宜的人口统计学特征和纳入标准,强调了当代研究的必要性。
    BACKGROUND: We investigated the long-term safety and efficacy of anatomical and extra-anatomical bypass for the treatment of unilateral iliac artery disease.
    METHODS: A systematic search on PubMed, Scopus and Web of science for articles published by June 2023 was performed. We implemented a 2-stage individual participant data meta-analysis and pooled survival probabilities using the multivariate methodology of DerSimonian and Laird. The primary endpoint was primary patency at 5 and 10 years of follow-up.
    RESULTS: Ten studies encompassing 1,907 patients were included. The 5- and 10-year pooled patency rates for anatomical bypass were 83.27% (95% confidence interval (CI): 69.99-99.07) and 77.30% (95% CI: 60.32-99.04), respectively, with a mean primary patency time representing the duration individuals remained event-free for 10.08 years (95% CI: 8.05-10.97). The 5- and 10-year pooled primary patency estimates for extra-anatomical bypass were 77.02% (95% CI: 66.79-88.80) and 68.54% (95% CI: 53.32-88.09), respectively, with a mean primary patency time of 9.25 years, (95% CI: 7.21-9.68). Upon 2-stage individual participant data meta-analysis, anatomical bypass displayed a decreased risk for loss of primary patency compared to extra-anatomical bypass, hazard ratio 0.51 (95% CI: 0.30-0.85). The 5- and 10-year secondary patency estimates for anatomical bypass were 96.83% (95% CI: 90.28-100) and 96.13% (95% CI: 88.72-100), respectively. The 5- and 10-year secondary patency estimates for extra-anatomical bypass were 91.39% (95% CI: 84.32-99.04) and 85.05% (95% CI: 74.43-97.18), respectively, with non-statistically significant difference between the 2 groups. The 5- and 10-year survival for patients undergoing anatomical bypass were 67.99% (95% CI: 53.84-85.85) and 41.09% (95% CI: 25.36-66.57), respectively. The 5- and 10-year survival for extra-anatomical bypass were 70.67% (95% CI: 56.76-87.98) and 34.85% (95% CI: 19.76-61.44), respectively. The mean survival time was 6.92 years (95% CI: 5.56-7.89) for the anatomical and 6.78 years (95% CI: 5.31-7.63) for the extra-anatomical groups. The pooled overall 30-day mortality was 2.32% (95% CI: 1.12-3.87) with metaregression analysis displaying a negative association between the year of publication and mortality (β =-0.0065, P < 0.01). Further analysis displayed a 30-day mortality of 1.29% (95% CI: 0.56-2.26) versus 4.02% (95% CI: 1.78-7.03), (P = 0.02) for studies published after and before the year 2000. Non-statistically significant differences were identified between the 2 groups concerning long-term and 30-day mortality outcomes.
    CONCLUSIONS: While we have demonstrated favorable long-term primary and secondary patency outcomes for both surgical techniques, anatomical bypass exhibited a reduced risk of primary patency loss potentially reflecting its inherent capacity to circumvent the anticipated disease progression in the distal aorta and the contralateral donor artery. The reduction in perioperative mortality observed in our review, coupled with the anachronistic demographic characteristics and inclusion criteria presented in the existing literature, underscores the imperative necessity for contemporary research.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    血管移植物钙化,包括聚对苯二甲酸乙二醇酯(PET)和膨胀聚四氟乙烯(ePTFE)移植物可能会导致移植物失败,但报道不足。这项研究的目的是回顾文献,以评估血管移植物钙化是否对血管移植物结局有害。
    搜索了Medline和Embase数据库。
    根据PRISMA指南,使用MeSH术语的组合搜索策略进行系统的文献检索。使用的MeSH术语是“钙化”,生理学\“,“钙质沉着”,“血管移植”,“血管假体”,“聚对苯二甲酸乙二醇酯”,和“聚四氟乙烯”。
    在35年的时间内,系统检索发现PET移植物钙化17例,ePTFE移植物钙化73例。在移植失败的移植物中报告了所有PET移植物钙化的病例。在心血管手术期间使用的移植物中意外地注意到了大多数ePTFE移植物钙化病例,随后将其移除。
    合成血管移植物钙化的报道不足,但可能损害移植物的长期性能。更多数据,需要包括放射学结果的具体分析以及外植体分析,以便对血管移植物钙化的患病率和发生率以及钙化对合成移植物结局的影响进行更敏感和具体的分析.
    UNASSIGNED: Calcification of vascular grafts, including polyethylene terephthalate (PET) and expanded polytetrafluoroethylene (ePTFE) grafts may contribute to graft failure, but is under reported. The aim of this study was to review the literature to assess whether vascular graft calcification is deleterious to vascular graft outcomes.
    UNASSIGNED: The Medline and Embase databases were searched.
    UNASSIGNED: A systematic literature search according to PRISMA Guidelines was performed using a combined search strategy of MeSH terms. The MeSH terms used were \"calcification, physiologic\", \"calcinosis\", \"vascular grafting\", \"blood vessel prosthesis\", \"polyethylene terephthalates\", and \"polytetrafluoroethylene\".
    UNASSIGNED: The systematic search identified 17 cases of PET graft calcification and 73 cases of ePTFE graft calcification over a 35 year period. All cases of PET graft calcification were reported in grafts explanted for graft failure. The majority of cases of ePTFE graft calcification were unexpectedly noted in grafts used during cardiovascular procedures and subsequently removed.
    UNASSIGNED: Calcification of synthetic vascular grafts is under reported but can compromise the long term performance of the grafts. More data, including specific analysis of radiological findings as well as explant analysis are needed to obtain a more sensitive and specific analysis of the prevalence and incidence of vascular graft calcification and the impact of calcification on synthetic graft outcomes.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Case Reports
    背景:在儿科人群中从未描述过感染的pop动脉假性动脉瘤。医生需要意识到它的呈现和管理,为了充分诊断和治疗这种疾病。
    方法:我们描述了一个14岁男孩的案例,他在打篮球后出现了以po窝为中心的肌炎和蜂窝织炎。开始静脉内治疗头孢唑啉。5天后,他经历了膝盖疼痛发作,结果是一种伴pop动脉假性动脉瘤的pop化脓性肌炎。对pop动脉进行了隐静脉移植旁路,并切除了pop假性动脉瘤。连续静脉注射头孢唑林6周,预防性使用乙酰水杨酸6个月。
    结论:该病例强调,如果软组织感染患者在使用适当的抗生素几天后出现持续性疼痛,则重复进行放射学检查的重要性。pop假性动脉瘤可以通过超声成像诊断,并通过pop-pop旁路治疗。我们的病人需要在手术后6个月的静脉移植物处进行导管引导的吻合术扩张,然后发展良好,并在扩张后6个月回到打篮球。
    BACKGROUND: An infected popliteal pseudoaneurysm has never been described in the pediatric population. Physicians need to be aware of its presentation and management, in order to diagnose and treat this medical condition adequately.
    METHODS: We describe the case of a 14-year-old boy who developed myositis and cellulitis centered at the popliteal fossa after playing basketball. A treatment of intravenous cefazolin was started. 5 days later, he experienced a knee pain flare-up, which turned out to be a popliteal pyomyositis with a pseudoaneurysm of the popliteal artery. A saphenous vein graft bypass of the popliteal artery and an excision of the popliteal pseudoaneurysm were performed. Intravenous cefazolin was continued for 6 weeks and prophylactic acetylsalicylic acid for 6 months.
    CONCLUSIONS: This case highlighted the importance of repeating radiologic investigations if a patient suffering from soft tissue infection has persistent pain after several days of appropriate antibiotics. A popliteal pseudoaneurysm can be diagnosed with ultrasound imaging and treated with a popliteal-popliteal bypass. Our patient needed a catheter-guided dilation of the anastomosis at the vein graft 6 months post-surgery, and then evolved favorably and went back to playing basketball 6 months post-dilation.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    pop动脉卡压综合征(PAES)是一种罕见的血管疾病,在每个受影响的腿中,与不同症状相关的双侧PAES病例非常罕见。为了提高当前对这种情况的表现和治疗的理解,本文描述了一例双侧PAES,并对相关文献进行了相应的综述.回顾性评估了诊断和治疗一名双侧PAES患者的总体过程,以提供有关该疾病的全面见解。该患者是通过对比增强计算机断层扫描(CT)诊断的,右侧有症状的PAES通过自体大隐静脉移植动脉旁路手术成功治疗。相比之下,该患者的无症状左侧PAES接受密切随访监测.术后随访2年,该患者未出现任何症状或并发症.因此,自体大隐静脉移植动脉旁路手术是治疗PAES的一种安全有效的方法,而对于无症状的PAES病例,即使是双侧表现的患者,也可能不需要手术。
    Popliteal artery entrapment syndrome (PAES) is a rare vascular disease, and cases of bilateral PAES associated with distinct symptoms in each of the affected legs are very rare. In an effort to improve current understanding regarding the presentation and treatment of this condition, a case of bilateral PAES is herein described with a corresponding review of the associated literature. The overall process of diagnosing and treating one patient affected by bilateral PAES was retrospectively assessed to provide comprehensive insight regarding this disease. This patient was diagnosed via contrast-enhanced computed tomography (CT), and right-sided symptomatic PAES was successfully treated via autogenous saphenous venous graft arterial bypass surgery. In contrast, the asymptomatic left-sided PAES in this patient was subject to close follow-up monitoring. Over a 2-year postoperative follow-up period, this patient did not experience any symptoms or complications. As such, autogenous saphenous venous graft arterial bypass surgery represents a safe and efficacious means of treating PAES, whereas surgery may not be required for cases of asymptomatic PAES even in patients with a bilateral presentation.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Case Reports
    一名62岁的男性在经皮冠状动脉介入治疗后1天出现短暂性脑缺血发作。磁共振成像显示左半球有新鲜的脑梗死。数字减影血管造影显示左Riles1A型颈总动脉闭塞(CCAO)。颈内动脉(ICA)的血流来自颈外动脉,通过左枕动脉和左椎动脉肌肉分支之间的吻合。我们用隐静脉进行了从CCA到ICA的短跳移植,然后结扎CCA。在1年的随访中,移植物仍保持专利。
    A 62-year-old man was presented with transient ischemic attack 1 day after percutaneous coronary intervention. Magnetic resonance imaging demonstrated fresh cerebral infarction in the left hemisphere. Digital subtraction angiography showed left Riles type 1A common carotid artery occlusion (CCAO). Blood flow in the internal carotid artery (ICA) was derived from the external carotid artery, which came through the anastomosis between the left occipital artery and a muscular branch of left vertebral artery. We performed short jump graft from CCA to ICA using saphenous vein, followed by ligation of CCA. The graft remained patent at the 1-year follow-up.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Case Reports
    一名患有Leriche综合征的47岁男性,由于TASCII型D型闭塞远端主动脉和总动脉而出现数字坏疽。使用Dacron主动脉-biliac旁路移植物进行开放式血运重建;然而,术后病程显示,他在戒断性精神病期间有未披露的静脉阿片类药物滥用史.我们的报告重点介绍了在可疑或确诊的静脉吸毒者中减轻与人工主动脉移植物相关的感染风险的方法。文献综述提出了替代策略,如主动脉动脉内膜切除术,使用非覆盖支架的全血管内途径,或混合方法。自体静脉移植物的主要使用应被视为最后的手段,以便在移植物感染的情况下保留静脉以供将来使用。患者因素,如合并症,适合接受手术,咬合的解剖学范围,由于缺乏基于证据的准则,设施/专门知识的可用性可以进一步指导管理计划。
    A 47-year-old male with Leriche syndrome presented with digital gangrene due to TASC II type-D occlusion of the distal aorta and common iliac arteries. Open revascularization was performed using a Dacron aorto-biiliac bypass graft; however, the postoperative course revealed a nondisclosed history of intravenous opioid abuse as he went into withdrawal psychosis. Our report highlights ways to mitigate infection risk associated with prosthetic aortic grafts in suspected or confirmed intravenous drug abusers. The literature review suggests alternative strategies like aortoiliac endarterectomy, total endovascular approach using non-covered stents, or a hybrid approach. The primary use of autologous venous grafts should be considered as a last resort so that the veins are retained for future use in case of graft infection. Patient factors like comorbidities, fitness to undergo surgery, anatomical extent of occlusion, and availability of facilities/expertise can further guide the management plan owing to a lack of evidence-based guidelines.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    血管移植物感染(VGI)是一种令人恐惧的并发症。预防是最重要的,血管移植涂层(VGC)可以提供这样做的潜力,体外研究是至关重要的第一步。这项研究的目的是总结研究预防VGI的涂层策略的体外模型的关键特征,以便为未来转化研究的建立提供指导。
    在MEDLINE中进行了全面搜索,Embase,和WebofScience。
    根据系统评价和荟萃分析指南的首选报告项目进行系统评价。对于每个数据库,制定了具体的搜索策略。使用毒理学数据可靠性评估工具(ToxRTool)评估质量。包括使用VGC和用病原体接种移植物的体外模型。移植物的类型,涂层,和病原体进行了总结。评估每个研究中的结果评估。
    总共,确定了4667项研究,其中45篇论文符合纳入标准。大多数使用聚酯接枝(68.2%)。31项研究(68.9%)包括抗生素,9项研究(20%)在其方案中使用了商业银移植物。新的抗菌策略(例如,蛋白水解酶)进行了研究。发现了多种测试方法,主要集中在细菌粘附上,涂层粘附和稀释,生物膜的形成,和细胞毒性。93%的研究(n=41)被认为是不可靠的。
    聚酯是优选的接枝涂层类型。大多数涂层研究是基于抗生素;然而,新的涂层策略(例如,抗生物膜涂层)来了。许多体外设置是可用的。体外研究有很大的潜力,他们可以限制使用,但不能完全取代体内研究。本文可作为今后体外研究的指导性文件。
    Vascular graft infection (VGI) is a feared complication. Prevention is of the utmost importance and vascular graft coatings (VGCs) could offer a potential to do this, with in vitro research a first crucial step. The aim of this study was to summarise key features of in vitro models investigating coating strategies to prevent VGI in order to provide guidance for the setup of future translational research.
    A comprehensive search was performed in MEDLINE, Embase, and Web of Science.
    A systematic review was conducted in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-analyses guidelines. For each database, a specific search strategy was developed. Quality was assessed with the Toxicological data Reliability Assessment Tool (ToxRTool). In vitro models using a VGC and inoculation of the graft with a pathogen were included. The type of graft, coating, and pathogen were summarised. The outcome assessment in each study was evaluated.
    In total, 4 667 studies were identified, of which 45 papers met the inclusion criteria. The majority used polyester grafts (68.2%). Thirty-one studies (68.9%) included antibiotics, and nine studies (20%) used a commercial silver graft in their protocol. New antibacterial strategies (e.g., proteolytic enzymes) were investigated. A variety of testing methods was found and focused mainly on bacterial adherence, coating adherence and dilution, biofilm formation, and cytotoxicity. Ninety-three per cent of the studies (n = 41) were considered unreliable.
    Polyester is the preferred type of graft to coat on. The majority of coating studies are based on antibiotics; however, new coating strategies (e.g., antibiofilm coating) are coming. Many in vitro setups are available. In vitro studies have great potential, they can limit the use, but cannot replace in vivo studies completely. This paper can be used as a guidance document for future in vitro research.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    近年来,在军事和平民创伤的背景下使用临时血管内分流器(TIVS)已经增长,主要是因为越来越多的证据表明肢体结局得到改善。我们试图通过对军事和民用文献的系统回顾来描述TIVS在创伤中的使用和结果。
    MEDLINE,EBSCO,EMBASE,在2000年1月至2021年3月之间发表的关于TIVS在军事和民用创伤环境中使用的研究中,搜索了Cochrane数据库。排除缺乏系统数据收集的报告以及TIVS描述性和结果数据不足的报告。评估了有关TIVS特征和结果的数据,并对军事和民用数据进行了集体综合。
    包括21份报告,14来自民用创伤中心或数据库,7来自军事现场数据或数据库(1,280名患者共1,380例分流)。16个是回顾性队列研究,四个是前瞻性的。五项研究有一个未分流的对照组。分流主要用于下肢,最常见于损伤控制适应症。停留时间很少报告,并且与分流血栓形成或其他并发症没有一致的联系。分流期间的抗凝治疗报告很少,并且应用不一致。分流肢体的损伤严重程度高于未分流肢体,但抢救率相似。
    暂时的血管内分流对于迅速恢复严重受伤的肢体的灌注是有效的,并且可能有助于挽救肢体。文献中缺乏比较TIVS数据,也没有一致应用的报告标准,所以关于TIVS使用的争议仍然存在。
    系统评价,四级。
    The use of temporary intravascular shunts (TIVS) in the setting of military and civilian trauma has grown in recent years, predominantly because of the mounting evidence of improved limb outcomes. We sought to characterize the use and outcomes of TIVS in trauma through a systematic review of military and civilian literature.
    The MEDLINE, EBSCO, EMBASE, and Cochrane databases were searched for studies on TIVS use in military and civilian trauma settings published between January 2000 and March 2021. Reports lacking systematic data collection along with those with insufficient TIVS descriptive and outcome data were excluded. Data regarding the characteristics and outcomes of TIVS were assessed and collective syntheses of military and civilian data performed.
    Twenty-one reports were included, 14 from civilian trauma centers or databases and 7 from military field data or databases (total of 1,380 shunts in 1,280 patients). Sixteen were retrospective cohort studies, and four were prospective. Five studies had an unshunted comparison group. Shunts were predominantly used in the lower extremity and most commonly for damage control indications. Dwell times were infrequently reported and were not consistently linked to shunt thrombosis or other complications. Anticoagulation during shunting was sparsely reported and inconsistently applied. Shunted limbs had higher injury severity than unshunted limbs but similar salvage rates.
    Temporary intravascular shunts are effective for expeditious restoration of perfusion in severely injured limbs and likely contribute to limb salvage. There is a paucity of comparative TIVS data in the literature and no consistently applied reporting standards, so controversies regarding TIVS use remain.
    Systematic Review, level IV.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

    求助全文

  • 文章类型: Journal Article
    探讨脉络膜前动脉(AChA)区圈闭部位与脑梗死的关系及颈内动脉血泡样动脉瘤(BLA)高流量分流术和病灶圈闭治疗的相关风险。
    我们纳入了26例诊断为BLAs并接受高流量旁路和诱捕的患者。我们检查了临床特征,包括年龄,动脉瘤陷阱位置,最终预后,脑梗塞术后磁共振成像,出院时改良Rankin量表评分。我们还搜索了类似研究的文献。
    20例患者出院时改良Rankin量表评分为0-2分,2名患者中有3-5名,2例患者中有6例。在19/26患者(73.1%)中,被困段位于后交通(PcomA)和眼动脉之间。在2例患者(7.7%)中,被困节段包括PcomA和AChA;4例患者(15.4%),被困段在PcomA内。在这些患者中,PcomA被阻塞,高流量旁路的血液单独流向AChA。无患者出现脑梗死。我们的系统评价确定了70例患者。在所有96名患者中,12人患有AChA脑梗塞;然而,梗死仅影响2例患者的预后。
    当用高流量旁路和病灶捕获治疗BLAs时,即使PcomA闭塞,AChA脑梗死的频率也很低,在高流量旁路期间,将AChA作为唯一的流出血管。然而,治疗C1-2附近晚期动脉硬化患者时,PcomA闭塞可能与风险相关。
    To examine the relationship between trap location and cerebral infarction in the anterior choroidal artery (AChA) region and associated risks in ruptured internal carotid artery blood blister-like aneurysm (BLA) treatment with high-flow bypass and lesion trapping.
    We included 26 patients diagnosed with BLAs and treated with high-flow bypass and trapping. We examined clinical characteristics including age, aneurysm trap location, final prognosis, cerebral infarction on postoperative magnetic resonance imaging, and modified Rankin Scale score at discharge. We also searched the literature for similar studies.
    The modified Rankin Scale score at discharge was 0-2 in 20 patients, 3-5 in 2 patients, and 6 in 2 patients. In 19/26 patients (73.1%), the trapped segment was between the posterior communicating (PcomA) and the ophthalmic arteries. In 2 patients (7.7%), the trapped segment included the PcomA and the AChA; in 4 patients (15.4%), the trapped segment was within the PcomA. In these patients, the PcomA was occluded, and blood from the high-flow bypass flowed out to the AChA alone. No patient showed cerebral infarction. Our systematic review identified 70 patients. Of all 96 patients, 12 had AChA cerebral infarction; however, the infarction affected the prognosis of only 2 patients.
    When treating BLAs with high-flow bypass and lesion trapping, the frequency of AChA cerebral infarction is low even when the PcomA is occluded, leaving the AChA as the only outflow vessel during high-flow bypass. However, PcomA occlusion may be associated with risks when treating patients with advanced arteriosclerosis near C1-2.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Sci-hub)

公众号